Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5721273A · kind A · utility
10Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1993 |
| Grant date | Feb 24, 1998 |
| Priority date | — |
| Expiry date | Dec 15, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/0016
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
9-Halo-13,14-dihydroprostaglandins are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.